Hierarchical nickel carbonate hydroxide nanostructures for photocatalytic hydrogen evolution from water splitting.

Metal carbonate hydroxides have emerged as novel and promising candidates for water splitting due to their good electrochemical properties and eco-friendly features. In this study, the hierarchical mesoporous structure of nickel carbonate hydroxide hydrate (Ni2(CO3)(OH)2·4H2O) was synthesized by a one-pot facile hydrothermal method. It demonstrated photocatalytic properties for the first time, exhibiting a hydrogen evolution reaction yield of 10 µmol g-1 h-1 under white light irradiation with a nominal power of 0.495 W. This facile synthesis strategy and the good photocatalytic properties indicate that nickel carbonate hydroxide is a promising material for application in photocatalytic hydrogen evolution.

Performance simulation of the perovskite solar cells with Ti3C2 MXene in the SnO2 electron transport layer.

MXenes, a class of two-dimensional (2D) transition metal carbides and nitrides, have a wide range of potential applications due to their unique electronic, optical, plasmonic, and other properties. SnO2-Ti3C2 MXene with different contents of Ti3C2 (0.5, 1.0, 2.0, 2.5 wt‰), experimentally, has been used as electron transport layers (ETLs) in Perovskite Solar Cells (PSCs). The SCAPS-1D simulation software could simulate a perovskite solar cell comprised of CH3NH3PbI3 absorber and SnO2 (or SnO2-Ti3C2) ETL. The simulation results like Power Conversion Efficiency (PCE), Open circuit voltage (VOC), Short circuit current density (JSC), Fill Factor (FF), and External Quantum Efficiency (EQE) have been compared within samples with different weight percentages of Ti3C2 MXene incorporated in ETL. Reportedly, the ETL of SnO2 with Ti3C2 (1.0 wt‰) effectively increases PCE from 17.32 to 18.32%. We simulate the role of MXene in changing the ideality factor (nid), photocurrent (JPh), built-in potential (Vbi), and recombination resistance (Rrec). The study of interface recombination currents and electric field shows that cells with 1.0 wt‰ of MXene in SnO2 ETL have higher values of ideality factor, built-in potential, and recombination resistance. The correlation between these values and cell performance allows one to conclude the best cell performance for the sample with 1.0 wt‰ of MXene in SnO2 ETL. With an optimization procedure for this cell, an efficiency of 27.81% is reachable.

Size-dependent interaction of plasma with anatase TiO2 nanoparticles.

We study the particle size distribution and phase changes of the anatase TiO2 nanopowder samples when they are subject to the plasma treatments of three different kinds of gases as nitrogen (N2), oxygen (O2), and argon (Ar). The plasma gas pressures vary as 0.1, 0.3, and 0.6 Torr. We demonstrate that the plasma treatments have an effect neither on the phase structure nor on the mean nanocrystalline size. The phase and size invariances of the samples are attributed to their nanoscale thermodynamic aspects. We find out that elevating the gas pressure in some cases creates fine-size amorphous nanoparticles with a narrow distribution. Our findings authenticate that plasma treatment affects the amorphous phase with etching particles down to a mean value of ∼3 nm. The small-angle X-ray scattering (SAXS) technique was utilized to obtain the size distribution of the nanoparticles, and the wide-angle X-ray scattering (WAXS) technique was used to probe the phase and size changes of the crystalline structure.

A computational approach to interface engineering of lead-free CH3NH3SnI3 highly-efficient perovskite solar cells.

Perovskite solar cells (PSCs) based on organic-inorganic metal halide perovskites are a recent ground-breaking advancement in attaining power conversion efficiencies exceeding 21%. However, the toxicity of lead in these PSCs could be a deterrent for large-scale development due to the environmental concerns. The methylammonium tin triiodide (CH3NH3SnI3) perovskite has been successfully employed in lead-free PSCs as an alternative to CH3NH3PbI3 perovskite. The PSCs have mostly been realized with a highly expensive spiro-OMeTAD hole-transporting material (HTM). Herein, copper thiocyanate (CuSCN) was implemented as a HTM instead of the highly expensive spiro-OMeTAD counterpart. The results show that CuSCN is a promising HTM for the lead-free CH3NH3SnI3-based PSCs. We investigated and optimized the parameters of the lead-free CH3NH3SnI3-based PSCs with the CuSCN HTM. The simulated device shows a power conversion efficiency exceeding 26% under AM 1.5G illumination and an absorption onset up to 1080 nm. The reported CH3NH3SnI3-based PSCs provide a viable path to the realization of environmentally benign, low-cost, and high-efficiency PSCs.

Radiochromic film-based quality assurance for CT-based high-dose-rate brachytherapy.

PURPOSE: In the past, film dosimetry was developed into a powerful tool for external beam radiotherapy treatment verification and quality assurance. The objective of this work was the development and clinical testing of the EBT3 model GafChromic film based brachytherapy quality assurance (QA) system. METHODS AND MATERIALS: Retrospective dosimetry study was performed to test a patient-specific QA system for preoperative endorectal brachytherapy that uses a radiochromic film dosimetry system. A dedicated phantom for brachytherapy applicator used for rectal cancer treatment was fabricated enabling us to compare calculated-to-measured dose distributions. Starting from the same criteria used for external beam intensity-modulated radiation therapy QA (3%, 3 mm), passing criteria for high- and low-dose gradient regions were subsequently determined. Finally, we investigated the QA system's sensitivity to controlled source positional errors on selected patient plans. RESULTS: In low-dose gradient regions, measured dose distributions with criteria of 3%, 3 mm barely passed the test, as they showed 95% passing pixels. However, in the high-dose gradient region, a more stringent condition could be established. Both criteria of 2%, 3 mm and 3%, 2 mm with gamma function calculated using normalization to the same absolute dose value in both measured and calculated dose distributions, and matrix sizes rescaled to match each other showed more than 95% of pixels passing, on average, for 15 patient plans analyzed. CONCLUSIONS: Although the necessity of the patient-specific brachytherapy QA needs yet to be justified, we described a radiochromic film dosimetry-based QA system that can be a part of the brachytherapy commissioning process, as well as yearly QA program.